We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$14.7B
AUM Growth
-$2.91B
Cap. Flow
-$2.63B
Cap. Flow %
-17.88%
Top 10 Hldgs %
6.52%
Holding
4,319
New
695
Increased
988
Reduced
1,077
Closed
1,450

Top Buys

Rank Stock Value
1
GM icon
General Motors
GM
+$66.2M
2
WFC icon
Wells Fargo
WFC
+$57M
3
SNOW icon
Snowflake
SNOW
+$53.6M
4
TMO icon
Thermo Fisher Scientific
TMO
+$52.1M
5
AVGO icon
Broadcom
AVGO
+$43.5M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$76.6M
2
ZTS icon
Zoetis
ZTS
+$67.5M
3
UBER icon
Uber
UBER
+$57.3M
4
MMM icon
3M
MMM
+$53.2M
5
NFLX icon
Netflix
NFLX
+$52.5M

Sector Composition

Rank Sector Weight
1 Technology 7.73%
2 Industrials 6.14%
3 Consumer Discretionary 5.41%
4 Financials 4.9%
5 Healthcare 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIOT icon
3851
Riot Platforms
RIOT
$7.76B
-304,446
Closed -$3.07M
RL icon
3852
Ralph Lauren
RL
$23.6B
-60,010
Closed -$10.4M
RLAY icon
3853
Relay Therapeutics
RLAY
$4.33B
-1,229
Closed -$10.2K
RLMD icon
3854
Relmada Therapeutics
RLMD
$527M
-51,161
Closed -$238K
RMBS icon
3855
CALL
Rambus
RMBS
$11B
-6,900
Closed -$426K
RMNI icon
3856
Rimini Street
RMNI
$471M
-42,436
Closed -$138K
RNG icon
3857
CALL
RingCentral
RNG
$5.28B
-13,000
Closed -$452K
ROIV icon
3858
Roivant Sciences
ROIV
$26.2B
-11,890
Closed -$125K
ROL icon
3859
Rollins
ROL
$18.2B
-22,468
Closed -$1.04M
RPD icon
3860
Rapid7
RPD
$773M
-149,860
Closed -$6.24M
RPRX icon
3861
Royalty Pharma
RPRX
$25.3B
-477,047
Closed -$14.5M
RPTX
3862
DELISTED
Repare Therapeutics
RPTX
-35,418
Closed -$167K
RS icon
3863
Reliance Steel & Aluminium
RS
$21.6B
-13,670
Closed -$4.57M
RSG icon
3864
Republic Services
RSG
$65.7B
-5,403
Closed -$1.02M
RSP icon
3865
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
-51
Closed -$8.64K
RTO icon
3866
Rentokil
RTO
$12.2B
-50,823
Closed -$1.53M
RVTY icon
3867
Revvity
RVTY
$12.8B
-4,569
Closed -$480K
RWAY icon
3868
Runway Growth Finance
RWAY
$287M
-77
Closed -$933
RXRX icon
3869
Recursion Pharmaceuticals
RXRX
$1.73B
-30,920
Closed -$308K
RXT icon
3870
Rackspace Technology
RXT
$1.24B
-40,133
Closed -$63.4K
RYAAY icon
3871
Ryanair
RYAAY
$31.3B
-7,075
Closed -$412K
RYAN icon
3872
Ryan Specialty Holdings
RYAN
$11B
-54,427
Closed -$3.02M
RYN icon
3873
Rayonier
RYN
$6.55B
-171,606
Closed -$5.18M
SA
3874
Seabridge Gold
SA
$3.35B
-16,281
Closed -$246K
SACH
3875
Sachem Capital Corp
SACH
$39.8M
-102,014
Closed -$455K

Similar funds

Cubist Systematic Strategies's Q2 2024 Portfolio in Review

As of Q2 2024, Cubist Systematic Strategies held 4,319 positions worth $14.7B, down 17% from $17.6B the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.

Cubist Systematic Strategies withdrew a net $2.63B in Q2 2024, closing 1,450 positions and reducing 1,077 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $76.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 11% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Cubist Systematic Strategies opened a new position in General Motors worth $68.2M.

  • Cubist Systematic Strategies's largest Q2 2024 buy was General Motors: 1,467,209 shares worth $68.2M.
  • Cubist Systematic Strategies added most to Thermo Fisher Scientific in Q2 2024, an estimated $52.1M increase.
  • Cubist Systematic Strategies's biggest Q2 2024 reduction was Uber, cutting an estimated $57.3M.
  • Cubist Systematic Strategies fully exited Meta Platforms (Facebook) in Q2 2024, selling an estimated $76.6M.
  • Cubist Systematic Strategies's ten largest holdings make up 6.5% of its $14.7B portfolio in Q2 2024.
  • Cubist Systematic Strategies opened 695 new positions and closed 1,450 in Q2 2024.
  • Cubist Systematic Strategies's portfolio value fell 17% quarter-over-quarter to $14.7B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.